AdvertiseDonate
LatestWellcome Backs Major Study of Britain's Planned Social Media Ban for Children
Wed, Nov 18, 2026Los AngelesNew YorkChicagoHoustonPhoenixPhiladelphiaSan FranciscoSeattleAtlantaBoston
World Herald Now · 20 Cabot Boulevard, Suite 300, Mansfield, MA 02048

India caps margins on 137 cancer drugs to cut costs

Prices for 137 medicines will drop by up to 70% starting next month, a move driven by a supreme court ruling against high retail mark-ups.

By Sofia Suzuki ·

Illustration for: India caps margins on 137 cancer drugs to cut costs
Illustration generated for this article, not a news photograph.

The Indian government will lower the price of 137 cancer medicines beginning in November. This action follows a supreme court decision that labeled high retail mark-ups as extortion. The new pricing rules aim to reduce the financial strain on patients who often sell assets or take on debt to pay for treatment.

The legal fight started with Sarojam Radhakrishnan, a retired bank clerk in Kerala. She was diagnosed with breast cancer in 2021 and prescribed targeted treatments. The monthly cost exceeded 63,000 rupees, or about 500 pounds, which her family could not afford. She petitioned the Kerala high court in 2022 to intervene.

Justices Vikram Nath and Sandeep Mehta reviewed the case at the supreme court. They noted that a drug supplied to hospitals for 2,700 rupees was sold to patients for 27,000 rupees. The court described the pricing situation as carnage and extortion. Analysis by the National Pharmaceutical Pricing Authority found average trade mark-ups of 170%, with some cases exceeding 700%.

The government previously limited trade margins to 30% for 42 specific drugs. It has now extended that cap to 137 additional medicines. The Department of Pharmaceuticals stated this measure should lower prices by up to 70%. It estimates patients will save 2,500 crore rupees, or 199 million pounds, every year.

The financial burden of cancer care in India is severe. Studies by the Public Health Foundation of India indicate that healthcare costs push about 55 million people below the poverty line annually. Insurance coverage remains limited. The government's Ayushman Bharat scheme offers 500,000 rupees in annual coverage per family. This amount equals the cost of one dose of Kadcyla, a breast cancer drug that may require up to 14 doses.

India records approximately 1.56 million new cancer cases per year, an increase from 1.39 million in 2020. Jyotsna Singh, co-convener of the Working Group on Access to Medicines and Treatments, called for a total overhaul of the healthcare system. She warned that hospitals might offset lower drug prices by raising other charges. The supreme court asked the government to explain why the cap does not apply to all non-patented medicines. The government must respond by 27 October. Radhakrishnan died in September 2022 while her case was pending.

More World · Report a business · Got a Story?

Get World Herald Now in your inboxThe stories that matter, every day. Free, a few times a week, unsubscribe any time.

Related stories

Get World Herald Now in your inboxThe stories that matter, every day. Free, a few times a week, unsubscribe any time.